In this study, we characterized the gut microbiota in 50 RM-NPC patients that received anti-PD-1 treatment, and excluded 9 in the following analysis due to confounding effects from antibiotics. The gene discussed is PDCD1; the disease is nasopharyngeal carcinoma.